Noninvasive Ventilation Strategies in the Age of COVID-19: An Evolving Story.

Over the past decade, use of noninvasive oxygenation strategies (NIOS) for the treatment of hypoxemic respiratory failure, consisting mainly of noninvasive ventilation (NIV) and high-flow nasal cannula (HFNC), has increased substantially despite a lack of supporting evidence.[1][1] In contrast, on